UniProt P01443
P01443
P01443 (UniProt P01443): 6 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P01443
- Experimental structures
- 6
- Predicted models
- 1
Structures
7 records of P01443 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1KBS | Solution structure of cardiotoxin IV, NMR, 1 structure | solution nmr | A | — | — |
| 1KBS | Solution structure of cardiotoxin IV, NMR, 1 structure | solution nmr | A | — | — |
| 1KBT | Solution structure of cardiotoxin IV, NMR, 12 structures | solution nmr | A | — | — |
| 1KBT | Solution structure of cardiotoxin IV, NMR, 12 structures | solution nmr | A | — | — |
| 4OM5 | Crystal structure of CTX A4 from Taiwan Cobra (Naja naja atra) | x-ray diffraction | A, B, C, D | — | — |
| 4OM5 | Crystal structure of ctx A4 from taiwan cobra (naja naja atra) | x-ray diffraction | A, B, C, D | — | — |
| P01443 | AlphaFold monomer V2.0 prediction for cytotoxin 4 (P01443) | predicted | A | — | — |
Experiment against prediction
- 4OM5 chain C against the predicted model P01443: TM-score 0.96, RMSD 0.61 Å
- 4OM5 chain C against the predicted model P01443: TM-score 0.96, RMSD 0.61 Å
- 4OM5 chain D against the predicted model P01443: TM-score 0.96, RMSD 0.63 Å
- 4OM5 chain D against the predicted model P01443: TM-score 0.96, RMSD 0.63 Å
- 4OM5 chain B against the predicted model P01443: TM-score 0.91, RMSD 1.06 Å
- 4OM5 chain B against the predicted model P01443: TM-score 0.91, RMSD 1.06 Å
- 4OM5 chain A against the predicted model P01443: TM-score 0.90, RMSD 1.16 Å
- 4OM5 chain A against the predicted model P01443: TM-score 0.90, RMSD 1.16 Å
- 1KBS chain A against the predicted model P01443: TM-score 0.66, RMSD 2.39 Å
- 1KBS chain A against the predicted model P01443: TM-score 0.66, RMSD 2.39 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.